NOV 13, 2020 6:00 PM PST

Q&A Session (In the RoundTable Room)

Speakers
  • Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
    Biography

      Charalambos Solomides began his career in medicine at the Rheinishe Friedrich-Wilhelms University of Bonn, Germany, where he attended Medical School. Following graduation in 1988 with a Degree in Medicine he successfully completed his medical doctorate thesis in 1991, and graduated from the same university with a Doctorate of Medicine (Dr. Med.). Following 2 years in clinical research at Albany Medical College in NY, USA (1991-1993), he enrolled in the Residency Pathology Program of Temple University Hospital (TUH) in Philadelphia (1993). He completed his Residency in Pathology in 1998 and a Fellowship in Cytopathology 1999 at Thomas Jefferson University. He joined the faculty at TUH, Department of Pathology in 1999 as Assistant and later as Associate Professor of Pathology and Director of Cytopathology (2004). In 2009 he joined the Department of Pathology at Thomas Jefferson University Hospital in Philadelphia where is currently The Warren R. Lang Professor of Pathology, Anatomy and Cell Biology and Director of Cytopathology and the Immunohistochemistry Lab. His special interest is in Cytopathology and Lung Pathology. Charalambos has published over 70 publications in peer reviewed journals and 2 book chapters.

    • Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
      Biography

        Sara Eglitis is a former scientist at NovoVita Histopath Laboratory, a CRO in Boston, MA specializing in a wide ranging of histopathology services including immunohistochemistry and digital image analysis. She is now Laboratory Director at StageBio.

      • Research associate, Memorial Sloan Kettering Cancer Center
        Biography

          Faruk Erdem Kombak is a research associate in Memorial Sloan Kettering Cancer Center, New York. He has been working in Precision Pathology Biobanking Center of this institution since September 2019. He was born in Turkey, in 1986 and completed his medical degree in Istanbul University, Turkey, in 2010. He finished his anatomical pathology residency in Marmara University, Turkey, in 2016. He worked as attending pathologist in Turkey for 3 years. In his current position; he performs histological and immunohistochemical assessment for clinical trials/scientific projects as well as multiplex immunohistochemistry and tissue microarray construction.

        • Staff Scientist
          Biography

            Srabani Bhaumik is a Staff Scientist in the Strategic Applications and Innovation Lab at Roche Tissue Diagnostics. Her R&D experiences includes molecular imaging, molecular pathology, small animal imaging, MRI contrast media imaging, reporter gene imaging, regenerative medicine and in-vitro assay development in oncology. Her current work is focused on fluorescent multiplexing (mIF) assay development on Roche automated IHC/ISH instruments, image acquisition and image analysis on multiple platforms. She was the technical lead for the development and launch of the fluorescent RUO 5-Plex assay on Roche Discovery platform. She has successfully developed complex fluorescent multiplex assays on various oncology samples including 3D cell spheroids and cytology. Prior to Roche, she worked at General Electric Global Research, where she focused on the MultiOmyx platform to explore immune oncology biomarker.

          • Research Leader, Roche Sequencing Solutions
            Biography

              Nelson Alexander received his Ph.D. in Cancer Biology from the University of Arizona, followed by a post-doctoral fellowship at Vanderbilt University. Looking to have a more direct impact on patient care, he joined Roche Tissue Diagnostics (RTD) in 2007 where he has held multiple roles in R&D, as well as Research & Early Development. During his time at RTD Nelson became very interested in the interface between tumor heterogeneity and sampling bias. Nelson currently lead a research team within Roche Sequencing Solutions that is pioneering a new sampling process that enables the evaluation and quantification of tumor diversity at the genomic, transcriptomic, and cellular levels from entire solid tumors.


            Abstract

            Visit the RoundTable Room to participate in live Q&A with all the speakers!


            Show Resources
            You May Also Like
            SEP 10, 2020 9:00 AM PDT
            C.E. CREDITS
            SEP 10, 2020 9:00 AM PDT
            Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
            SEP 03, 2020 9:00 AM PDT
            C.E. CREDITS
            SEP 03, 2020 9:00 AM PDT
            DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
            C.E. CREDITS
            This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
            JUN 17, 2020 1:30 PM PDT
            C.E. CREDITS
            JUN 17, 2020 1:30 PM PDT
            Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
            NOV 05, 2020 7:00 AM PST
            C.E. CREDITS
            NOV 05, 2020 7:00 AM PST
            DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
            NOV 19, 2020 8:00 AM GMT
            C.E. CREDITS
            NOV 19, 2020 8:00 AM GMT
            Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
            Loading Comments...
            Show Resources